Xi'an Hao-Xuan Biological Technology
Xi'an Hao-xuan Biotechnology Co., Ltd. is a high-tech enterprise engaged in the development, production, and sale of plant-based pharmaceutical intermediates and natural extracts. Based in Xi'an, with production operations in Baqiao District, the company emphasizes the modernization of traditional Chinese medicine and the integration of plant-based materials into multiple industries including Chinese medicine, chemicals, food, and health products.
The organization highlights its status as a promoter of traditional Chinese medicine modernization, positioning its products across three main series: plant extracts, single extracts, and pharmaceutical intermediates. The portfolio covers more than 100 varieties designed to meet diverse customer requirements. In terms of capabilities, Xi'an Hao-xuan Biotechnology reports the use of modern large-scale extraction equipment, several chromatography systems, and advanced high-performance liquid chromatography (HPLC) for testing and quality assurance. These facilities support a broad production spectrum, from herbal material processing to refined chemical intermediates, ensuring consistent product quality and traceability.
A core emphasis of the company lies in its production and processing capacity, with the referenced capacity for herbal and plant-derived materials and fine monomer production. The organization describes a comprehensive approach to manufacturing, including dedicated teams responsible for production, testing, and packaging to maintain industry-leading product quality. This integrated manufacturing model aligns with the demands of customers across pharmaceutical intermediates and plant-based product markets, reinforcing Hao-xuan’s commitment to reliability and performance.
The company’s philosophy centers on integrity and practical collaboration, articulating a willingness to engage with partners and peers to advance shared goals. While the available material outlines a broad capability set and a strategic focus on traditional Chinese medicine modernization, it does not provide detailed product specifications, regulatory certifications, or export logistics information. For potential partners and customers, the emphasis remains on quality control, scalable production, and a diverse product lineup designed to support research, development, and production needs in related sectors.
Overall, Xi'an Hao-xuan Biotechnology Co., Ltd. presents itself as a vertically integrated operation with a focus on natural plant-derived resources and pharmaceutical intermediates. Its facilities and process capabilities are described as modern and capable of handling significant volumes, while its market positioning reflects a commitment to advancing traditional Chinese medicine through modern extraction, purification, and analytical techniques. Further information on regulatory compliance, geographic reach, and specific product specifications would provide a more comprehensive view of the company’s capabilities and market footprint.
